Celladon
Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.
Funding reportedLast round: Post ipo equity
Follow Celladon and see its new rounds in your feed.Start following
What company datasets say Celladon raised
Funding, as reported
Reported in all152.5Min the source's currency
Rounds12
Last roundPost ipo equity
Last round dateNov 2015
Investors listed18
On a portfolio page
Investors who name them
Each firm lists Celladon on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Celladon in front of investors. Or tell us what we have wrong.